Algert Global LLC Eagle Pharmaceuticals, Inc. Transaction History

Algert Global LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$53.25 - $59.98 $267,474 - $301,279	-5,023 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$46.61 - $58.45 $649,976 - $815,085	-13,945 Reduced 73.52%	5,023 $280,000
Q1 2019 May 01, 2019	SELL	$38.66 - $51.82 $108,673 - $145,666	-2,811 Reduced 12.91%	18,968 $958,000
Q4 2018 Feb 01, 2019	BUY	$36.72 - $67.73 $574,153 - $1.06 Million	15,636 Added 254.53%	21,779 $877,000
Q3 2018 Nov 14, 2018	BUY	$66.65 - $83.86 $409,430 - $515,151	6,143 New	6,143 $426,000

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $8.46M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.